Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Supreme Court Rules for Roundup Manufacturer in Cancer Case

The Supreme Court sided with the herbicide manufacturer in a case brought by a Missouri man who attributed his cancer to Roundup exposure. The ruling is expected to impact thousands of similar cases across the country.

07/18/2026 · Iowa edition

Advertisement

Advertisement

Why it matters locally: Iowa, a leading agricultural state, sees widespread use of herbicides like Roundup by farmers, landscapers, and homeowners. This Supreme Court decision could impact future legal avenues for individuals in Iowa who attribute health issues to exposure to similar products.

The Supreme Court voted 7-2 to overturn a jury award in a case where a Missouri man claimed that exposure to Roundup caused his cancer. The decision favored the herbicide's manufacturer and is expected to affect the viability of thousands of pending lawsuits filed in courts nationwide. The jury had previously awarded the plaintiff compensation. The Supreme Court's majority opinion reversed that judgment, altering the legal standards that govern such claims. Dr. Chadi Nabhan, who authored a book examining the Monsanto trials and litigation over the herbicide, discussed the ruling's implications. Nabhan has written extensively on the legal battles surrounding Roundup exposure claims. Scientific research on the herbicide's health effects has produced conflicting findings. The International Agency for Research on Cancer classified glyphosate, Roundup's active ingredient, as probably carcinogenic in 2015. The U.S. Environmental Protection Agency reached a different conclusion in 2020, stating the chemical was unlikely to pose a cancer risk to humans at the exposure levels Americans typically encounter. Farmers, landscapers and homeowners have used Roundup for decades as a broad-spectrum herbicide. The product became one of the world's most widely used agricultural chemicals after its introduction in the 1970s. Plaintiffs in the litigation attributed their cancers to occupational or residential contact with the herbicide. They sought compensation from the manufacturer based on allegations that the company failed to adequately warn consumers about potential health risks. The court's decision removes a major avenue for additional lawsuits to proceed. Legal experts said the ruling sets a precedent that will make it substantially harder for future plaintiffs to bring similar cases to trial.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Iowa

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Iowa

health

Transgender Inmates Challenge Federal Prison Policy on Healthcare Access

Attorneys representing transgender inmates have urged the Supreme Court to maintain a lower court's order. This order currently blocks the Federal Bureau of Prisons from enforcing a new policy restricting healthcare and social accommodations for transgender prisoners. The policy, implemented by the Trump administration, eliminates access to hormone therapy and items like makeup and wigs.

Read Story →
health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
health

Report Examines Impact of Trump Administration's Drug Pricing Initiatives

A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.

Read Story →
health

Cost of GLP-1 Medications Prompts Search for Alternatives

Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.

Read Story →
health

Experimental Vaccine Shows Promise Against Glioblastoma

An experimental vaccine for glioblastoma, a severe form of brain cancer, demonstrates potential to prolong life for patients. Developers report encouraging results from ongoing studies.

Read Story →
Scroll for more stories